MedPath

A longitudinal non-invasive study of changes in urinary bladder contractility secondary to benign prostatic hyperplasia.

Not Applicable
Completed
Conditions
Benign Prostatic Hyperplasia (BPH)
Urological and Genital Diseases
Registration Number
ISRCTN46624580
Lead Sponsor
Erasmus Medical Centre (Netherlands)
Brief Summary

2014 results in https://pubmed.ncbi.nlm.nih.gov/23423651/ (added 10/06/2021)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
1020
Inclusion Criteria

1. Men aged 38 - 77 years
2. Mentally and physically able to complete a voiding diary and to visit the outpatient clinic
3. Written informed consent to participate in the trial

Exclusion Criteria

1. Unable to urinate in a standing position
2. Previous lower urinary tract surgery
3. Congenital disease of the lower urinary tract
4. Use of medication or other interventions for lower urinary tract symptoms
5. Other diseases that could alter urinary function (e.g., Parkinsons, Cerebrovascular Accident [CVA], Diabetes Mellitus [DM], kidney failure, bladder/prostate cancer, current urinary tract infection)
6. Heart failure
7. Voiding pattern at first visit incompatible with measurement technique, e.g., flow rate too low (less than 6 ml/s), interrupted voiding, straining
8. Mentally or physically unable to complete a voiding diary and to visit the outpatient clinic
9. Use anticoagulants

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The study is observational, there is no endpoint.
Secondary Outcome Measures
NameTimeMethod
o secondary outcome measures
© Copyright 2025. All Rights Reserved by MedPath